Updated:
Spruce Capital Partners
Spruce Capital Partners is an exempt reporting adviser in South San Francisco, CA. It advises clients on investment strategies. The firm is headquartered in...
Overview
Spruce Capital Partners is an exempt reporting adviser in South San Francisco, CA. It advises clients on investment strategies. The firm is headquartered in South San Francisco.
General information
Firm type
Venture Capital
Year founded
2013
Location
Region
North America
Country
United States
City
South San Francisco
Corporate office
San Francisco, CA, United States
Sector focus
Frequently asked questions
What is the core investment thesis of Spruce Capital Partners?
The firm focuses on venture-stage companies that apply advanced biology, data science, and digital tools to agriculture, nutrition, and industrial life sciences. Its portfolio spans engineered microbes, gene-editing platforms, crop coatings, and spectroscopic phenotyping — technologies that aim to improve crop yields, reduce chemical inputs, and enhance nutritional density across the food supply chain.
Which notable portfolio companies has Spruce Capital Partners backed?
The firm's disclosed positions include Pivot Bio, which commercialized nitrogen-fixing microbes to replace synthetic fertilizer; Inscripta, which developed an automated CRISPR platform for microbial engineering; and Provivi, which makes insect pheromones for pesticide-free crop protection. Additional disclosed holdings include Consumer Physics, Crop Enhancement, GreenLight Biosciences, Evolve BioSystems, Amfora, and AGERpoint (per the firm's website).
Is Spruce Capital Partners a corporate venture arm or an independent firm?
Spruce Capital Partners operates as an independent venture capital firm headquartered in San Francisco. It is not a corporate venture arm of a larger agribusiness or pharmaceutical company, and there is no publicly disclosed parent entity steering its investment decisions.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: